Ujvira 100mg Injection (TRASTUZUMAB EMTANSINE)

Ujvira is an anti-cancer medicine  for the treatment of HER2-positive cancers. It contains trastuzumab-based therapy and is primarily used in patients with HER2-positive breast cancer.

Category:

Description

Ujvira Drug: Uses, Benefits, and Important Information

Ujvira is an anti-cancer medicine developed by Zydus Healthcare for the treatment of HER2-positive cancers. It contains trastuzumab-based therapy and is primarily used in patients with HER2-positive breast cancer. In some cases, it may also be used for HER2-positive metastatic gastric (stomach) cancer. Ujvira was introduced to improve access to advanced cancer treatment while reducing treatment costs for patients.

How Ujvira Works

Ujvira targets the HER2 (Human Epidermal Growth Factor Receptor 2) protein found in excessive amounts on certain cancer cells. By attaching to these receptors, the drug helps stop cancer cell growth and enables the body’s immune system to attack and destroy the cancer cells.

Medical Uses

  • HER2-positive breast cancer
  • Advanced or metastatic HER2-positive breast cancer
  • HER2-positive gastric or gastroesophageal junction cancer in selected patients

Administration

Ujvira is given as an injection or infusion under the supervision of qualified healthcare professionals in a hospital or cancer treatment center. Patients should not self-administer this medication.

Possible Side Effects

Common side effects may include:

  • Fatigue
  • Fever and chills
  • Nausea and vomiting
  • Diarrhea
  • Headache
  • Cough
  • Rash
  • Injection-site reactions
  • Bone or back pain

Serious side effects can include heart-related problems, lung toxicity, and severe allergic reactions. Regular monitoring by a healthcare provider is important during treatment.

Precautions

  • Not recommended during pregnancy because it may harm the unborn baby.
  • Breastfeeding should generally be avoided during treatment.
  • Patients with heart, lung, liver, or kidney conditions should inform their doctor before starting therapy.

Conclusion

Ujvira is an important targeted therapy for HER2-positive cancers. By specifically targeting cancer cells that overexpress the HER2 protein, it can improve treatment outcomes while reducing damage to healthy cells. Patients should use this medication only under specialist medical supervision and follow all monitoring recommendations provided by their healthcare team.

Reviews

There are no reviews yet.

Be the first to review “Ujvira 100mg Injection (TRASTUZUMAB EMTANSINE)”

Your email address will not be published. Required fields are marked *